ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Yoshikatsu Koga, Satoshi Katayose, Nobuko Onoda, Takahiro Kasamatsu, Tomoyasu Kato, Shunichi Ikeda, Mitsuya Ishikawa, Ken Ishitani, Yasuo Hirai, Hideo Matsui, Yasuhiro Matsumura
A simple and non-invasive method for detecting endometrial cancer in women with abnormal uterine bleeding is r e quired. For this purpose, we prepared immuno-magnetic beads conjugated with anti-human EpCAM rat monoclonal antibody (mAb) for isolating exfoliate…
Zviad Kovziridze, Paata Khorava, Nunu Mitskevich
Average size of hematite and magnetite micro and nanopowders and polydispersity index, zeta potential and distribution of particles were studied. Analysis showed that average size of the obtained particles for magnetite is 740.9 nm, for hematite particles 30…
Mohamed Fawzy, Mai Saleh, Mohamed El-Wakil, Zeinab Monir, Eman Eltahlawy
Background and Objectives : Cancer treatments leading to increased survival rates are reported to participate in the creation of debilitating physical and psychosocial deficits for cancer survivors. Measures of health-related quality of life (HRQOL) are desig…
Yousaf Khan, J. Eduardo Villarreal-Barajas, Mona Udowicz, Richie Sinha, Wazir Muhammad, Ahmed N. Abbasi, Amjad Hussain
Purpose : The main objective of the study was to evaluate the effect of air gaps of 0 - 5.0 cm between bolus and skin for 1.0 cm Superflab bolus on surface dose (D Surf ) and depth of maximum dose (d max ) in solid water and Rando ? phantoms. Methods : In thi…
Okid Parama Astirin, Anief Nur Artanti, Meutia Srikandi Fitria, Eva Agustina Perwitasari, Adi Prayitno
Introduction: Now many studies conducted on the drug substance from nature that can serve as an anticancer agent as a potential chemoprevention agent , such as Annona muricata Linn leaf escort chemotherapy , which was flaring. The cancer cell in humans was in…
Andrea Messori, Valeria Fadda, Dario Maratea, Sabrina Trippoli
In patients with epithelian ovarian cancer who have achieved remission after initial surgery and induction chemotherapy, the role of maintenance chemotherapy is controversial. We carried out a trial-sequential analysis that included 4 randomised controlled tr…
Mieko Yanagisawa, Keigo Yorozu, Mitsue Kurasawa, Yoichiro Moriya, Naoki Harada
We examined the antitumor efficacy of the capecitabine (CAPE) plus cyclophosphamide (CPA) combination as a 2 nd -line therapy after paclitaxel (PTX) plus bevacizumab (BEV) treatment in a xenograft model of human triple negative breast cancer (TNBC) cell line,…
Mohamed A. E. Salem, Hamza A. Hamza, Gamal Amira, Abeer E. Ibrahium, Ahmed A. S. Salem
Background: Rectal cancer accounts for the largest distribution within one anatomical region of the large bowel, with approximately one third of all CRC located within the rectum. The Golden standard treatment of primary rectal cancer is curative surgical res…
Marco Vacante, Giulia Malaguarnera, Manuela Pennisi, Giuseppe Grosso, Salvatore Salomone, Filippo Drago, Erdogan Ozyalcin, Vito Catania, Alfredo Consoli, Mariano Malaguarnera
Background: Although the majority of breast cancer patients are able to work, lower work ability and reduced job retention have been reported . The aim of the present study was to evaluate the effect of chemotherapy with capecitabine in patients with breast c…
Dekel Shlomi, Amir Onn, Maya Gottfried, Jair Bar, Haim Biran, Maya Ilouze, Addie Dvir, Hovav Nechushtan, Lior Soussan-Gutman, Nir Peled
Background : In the last decade, the search for gene mutations in lung cancer has been constantly growing. EGFR, KRAS mutations and, recently, the EML4 - ALK fusion can guide the selection of treatment for patients who carry a specific mutation. Methods : Dur…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).